 |
Live attenuatedListeria monocytogenesbioengineered with a chimeric human epidermal growth factor receptor 2 fused to a truncated form of the Lm protein listeriolysin O |
|---|---|
| Trade Name | |
| Orphan Indication | Pediatric osteosarcoma |
| EU Market Approval | EU |
| EU Designation Date | 2015-12-14 00:00:00 |
| Sponsor | Coté Orphan Consulting UK Limited |
